These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31076311)

  • 1. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.
    Wieruszewski PM; Sims CR; Daly RC; Taner T; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2366-2367. PubMed ID: 31076311
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
    Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
    J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.
    Weinberg D; Running K; Kalarickal PL; Patel GP
    Transplant Proc; 2021 May; 53(4):1300-1302. PubMed ID: 33246585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
    Cutler NS; Rasmussen BM; Bredeck JF; Lata AL; Khanna AK
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2756-2762. PubMed ID: 32868151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
    Trethowan B; Michaud CJ; Fifer S
    Crit Care Med; 2020 Oct; 48(10):e912-e915. PubMed ID: 32931196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting.
    Sovic W; Mathew C; Blough B; Monday KA; Sam T; Zafar H; Guerrero-Miranda C; Sherwood M; Hebert C; Hall S; Alam A
    Methodist Debakey Cardiovasc J; 2021; 17(4):98-101. PubMed ID: 34824689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Vasoplegic Shock After Heart Transplant Successfully Treated With Multimodal Therapeutic Approach.
    Jenkins FS; Aubin H; Boeken U; Lichtenberg A
    Exp Clin Transplant; 2024 May; 22(5):406-408. PubMed ID: 38970287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoplegia from Continuous Flow Left Ventricular Assist Devices.
    Sathianathan S; Bhat G; Dowling R
    Curr Cardiol Rep; 2021 Jul; 23(8):101. PubMed ID: 34196837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
    Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Vasoplegic Syndrome With Intravenous Hydroxocobalamin During Liver Transplantation.
    Boettcher BT; Woehlck HJ; Reck SE; Hong JC; Zimmerman MA; Kim J; Zundel MT; Freed JK; Pagel PS
    J Cardiothorac Vasc Anesth; 2017 Aug; 31(4):1381-1384. PubMed ID: 28012726
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of IgM-enriched Immunoglobulin for Vasopressor-resistant Vasoplegic Shock After Liver Transplantation.
    Willuweit K; Bezinover D; Herzer K; Nowak KM; Paul A; Saner FH
    Transplantation; 2019 Feb; 103(2):381-386. PubMed ID: 29944619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
    Busse LW; Barker N; Petersen C
    Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
    Chow JH; Strauss E; Mazzeffi MA
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):59-60. PubMed ID: 32950345
    [No Abstract]   [Full Text] [Related]  

  • 14. The response to methylene blue in patients with severe hypotension during liver transplantation.
    Cheng SS; Berman GW; Merritt GR; Hendrickse A; Fiegel MJ; Teitelbaum I; Campsen J; Wachs M; Zimmerman M; Mandell MS
    J Clin Anesth; 2012 Jun; 24(4):324-8. PubMed ID: 22608589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series.
    Konkol SB; Morrisette MJ; Hulse MC; Enfield KB; Mihalek AD
    Ann Card Anaesth; 2022; 25(3):359-361. PubMed ID: 35799569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
    Papazisi O; Palmen M; Danser AHJ
    Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation.
    Fischer GW; Bengtsson Y; Scarola S; Cohen E
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):463-6. PubMed ID: 18835528
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery.
    Suero OR; Park Y; Wieruszewski PM; Chatterjee S
    Crit Care Clin; 2024 Jan; 40(1):73-88. PubMed ID: 37973358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.
    Chow JH; Galvagno SM; Tanaka KA; Mazzeffi MA; Chancer Z; Henderson R; McCurdy MT
    A A Pract; 2018 Oct; 11(7):175-180. PubMed ID: 29688923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.